Literature DB >> 7615274

Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer.

P Gibson1, O Rosella, R Nov, G Young.   

Abstract

The hypothesis that the colonic epithelium is diffusely abnormal in ulcerative colitis was examined by comparing disease related responses in expression of markers of differentiation by colonic crypt cells to culture with and without butyrate. Cells were isolated from patients with normal colon (15), cancer (24), ulcerative colitis (19), or Crohn's disease (16). Alkaline phosphatase activities were measured in cell homogenates and the rate of glycoprotein synthesis assessed at the end of 24 hours of culture and expressed relative to the rate of protein synthesis as the G:P ratio. Alkaline phosphatase activities, but not G:P ratios, differed across the groups before and after 24 hour culture (p < 0.05), activities being lowest in the cancer group and highest in inflammatory bowel disease groups. Butyrate (1 mM) suppressed alkaline phosphatase activities in the cancer group by mean (SEM) of 17 (4) (p = 0.006) compared with no change in the other groups. Butyrate suppressed G:P ratios only in the cancer (6 (3)%, p = 0.03) and ulcerative colitis groups (5 (3)%, p = 0.04) and the changes in both were different (p < 0.05) from those in normal cells (increase of 10 (7)%). Changes in ulcerative colitis were different from those in Crohn's disease (p = 0.029). Responses were independent of the presence or absence of mucosal inflammation. These data confirm the diffuse nature of epithelial abnormalities in colorectal cancer. In ulcerative colitis, a different pattern of abnormality occurs, supporting the notion that the epithelium is also diffusely abnormal independent of mucosal inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615274      PMCID: PMC1382623          DOI: 10.1136/gut.36.6.857

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Cell renewal in the human rectum. In vitro autoradiographic study on active ulcerative colitis.

Authors:  H Bleiberg; P Mainguet; P Galand; J Chretien; N Dupont-Mairesse
Journal:  Gastroenterology       Date:  1970-06       Impact factor: 22.682

3.  Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.

Authors:  P Gibson; O Rosella; G Rosella; G Young
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

4.  Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse.

Authors:  A Allan; J B Bristol; R C Williamson
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

5.  Proliferative patterns in colonic mucosa in familial polyposis.

Authors:  E E Deschner; M Lipkin
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

6.  Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis.

Authors:  D K Podolsky; K J Isselbacher
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

7.  Rate and pattern of epithelial cell proliferation in ulcerative colitis.

Authors:  E P Serafini; A P Kirk; T J Chambers
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

8.  Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.

Authors:  A J Greenstein; D K Panvelliwalla; L B Katz; T M Heimann; J Donnelly; D Pertsimlidis; S Geller; H Smith; A H Aufses
Journal:  Am J Gastroenterol       Date:  1982-04       Impact factor: 10.864

9.  Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon.

Authors:  A K Shamsuddin; L Weiss; P C Phelps; B F Trump
Journal:  J Natl Cancer Inst       Date:  1981-02       Impact factor: 13.506

10.  Hepatic clearance of rat plasma intestinal alkaline phosphatase.

Authors:  G P Young; I S Rose; S Cropper; S Seetharam; D H Alpers
Journal:  Am J Physiol       Date:  1984-10
View more
  13 in total

1.  Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29.

Authors:  R G Clarke; E K Lund; P Latham; A C Pinder; I T Johnson
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

Review 2.  Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?

Authors:  P R Gibson; J G Muir
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.

Authors:  Bobak Parang; Andrew M Kaz; Caitlyn W Barrett; Sarah P Short; Wei Ning; Cody E Keating; Mukul K Mittal; Rishi D Naik; Mary K Washington; Frank L Revetta; J Joshua Smith; Xi Chen; Keith T Wilson; Thomas Brand; David M Bader; William P Tansey; Ru Chen; Teresa A Brentnall; William M Grady; Christopher S Williams
Journal:  Gut       Date:  2016-01-14       Impact factor: 23.059

4.  Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.

Authors:  Maciej Chichlowski; Greg S Westwood; Soman N Abraham; Laura P Hale
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

5.  Effects of cathepsin K deficiency on intercellular junction proteins, luminal mucus layers, and extracellular matrix constituents in the mouse colon.

Authors:  Maria Arampatzidou; André Schütte; Gunnar C Hansson; Paul Saftig; Klaudia Brix
Journal:  Biol Chem       Date:  2012-12       Impact factor: 3.915

6.  Impairment of mitochondrial acetoacetyl CoA thiolase activity in the colonic mucosa of patients with ulcerative colitis.

Authors:  Srikanth Santhanam; Aparna Venkatraman; Balakrishnan S Ramakrishna
Journal:  Gut       Date:  2007-05-04       Impact factor: 23.059

7.  Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma.

Authors:  E M Nilsen; K E Lundin; P Krajci; H Scott; L M Sollid; P Brandtzaeg
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

8.  Carbonic anhydrase I reduction in colonic mucosa of patients with active ulcerative colitis.

Authors:  R Fonti; G Latella; R Caprilli; G Frieri; A Marcheggiano; Y Sambuy
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

9.  Role of Corticotropin-releasing Factor in Gastrointestinal Permeability.

Authors:  Bruno K Rodiño-Janeiro; Carmen Alonso-Cotoner; Marc Pigrau; Beatriz Lobo; María Vicario; Javier Santos
Journal:  J Neurogastroenterol Motil       Date:  2015-01-01       Impact factor: 4.924

Review 10.  Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics.

Authors:  Luca Pastorelli; Carlo De Salvo; Joseph R Mercado; Maurizio Vecchi; Theresa T Pizarro
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.